Literature DB >> 18336752

Dilated cardiomyopathy due to thrombotic microangiopathy as the only manifestation of antiphospholipid syndrome: a case report.

F Vaccaro, D Caccavo, E Roumpedaki, G De Vincentis, C R T Di Gioia, P Gallo, P Palange.   

Abstract

Dilated cardiomyopathy due to thrombotic microangiopathy has been rarely reported as a clinical manifestation of antiphospholipid syndrome (APS). We describe the case of a 39-year-old woman affected by systemic lupus erythematosus (SLE) and positive antiphospholipid antibodies (aPL) who presented with orthopnea and peripheral oedema. Diagnosis of dilated cardiomyopathy due to myocardial thrombotic microangiopathy was made and treatment with anticoagulants prevented the worsening of the clinical condition. Interestingly, at variance with other cases, our patient showed no extracardiac signs of APS. The review of the current literature has confirmed that dilated cardiomyopathy due to thrombotic microangiopathy is a rare manifestation of APS.

Entities:  

Mesh:

Year:  2008        PMID: 18336752     DOI: 10.1177/039463200802100128

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  4 in total

1.  Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: A case series and review.

Authors:  Melody Hermel; David Hermel; Saif Azam; Jerold Shinbane; Annahita Sarcon; Erika Jones; Arjun Mehta; Luanda Grazette; Howard Liebman; Ilene Weitz
Journal:  EJHaem       Date:  2020-07-31

2.  Primary antiphospholipid syndrome, hypertrophic non-obstructive cardiomyopathy and hypotelorism.

Authors:  Joerg Kellermair; Juergen Kammler; Peter Laubichler; Clemens Steinwender
Journal:  BMJ Case Rep       Date:  2016-04-05

Review 3.  An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions.

Authors:  Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Lucia Ciucciarelli; Anna Maria Cameli; Gentian Denas; Mario Milco D'Elios; Vittorio Pengo; Lorenzo Emmi; Domenico Prisco
Journal:  ScientificWorldJournal       Date:  2014-10-14

Review 4.  Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form.

Authors:  Tamara Kolitz; Shachaf Shiber; Itzhak Sharabi; Asher Winder; Gisele Zandman-Goddard
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.